Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with synthetic cohort
Authors:
- Steve KantersSKSteve Kanters
- Marina KleinMKMarina Klein
- Prosanto ChaudhuryPCProsanto Chaudhury
- Paul MarottaPMPaul Marotta
- Phil WongPWPhil Wong
- Norman KnetemanNKNorman Kneteman
- Edward J MillsEMEdward J Mills
- 27 March 2011
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 25 (6) , 777-786
Abstract
The relative success of liver transplantation in those with HIV compared to HIV-uninfected individuals remains a point of intense debate. We aimed to evaluate the effectiveness of liver transplantation in HIV-hepatitis co-infected patients using a meta-analysis and individual patient data meta-analysis as a synthetic cohort. We searched MEDLINE via PubMed, EMBASE, Cochrane CENTRAL, AIDSLINE (inception to 2010), AMED, CINAHL, TOXNET, Development and Reproductive Toxicology, Hazardous Substances Databank, Psych-info and relevant conferences. We included cohort studies and individual case-reports evaluating survival of co-infected transplant patients. We abstracted data on cohort and case demographics and outcomes. We pooled cohorts using a random-effects analysis and created a synthetic cohort of cases using individual patient data. We confirmed this with the pooled cohort analysis. We included 15 cohort studies and 49 case series with individual patient data. At 12 months, 84.4% [95% confidence interval (CI) 81.1-87.8%] of patients had survived. Within the HIV-infected population evaluated, HIV-hepatitis B virus (HBV) co-infection was associated with optimal survival. In an adjusted model, individuals positive for HBV were 8.28 (95% CI 2.26-30.33) times more likely to survive when compared to those without HBV. Further, individuals with an undetectable HIV viral load at the time of transplantation were 2.89 (95% CI 1.41-5.91) times more likely to survive when compared to those with detectable HIV viremia. Hepatitis C virus was not a predictor of patient survival when adjusted for by other key predictors [0.54 (95% CI 0.17-1.80)].Keywords
This publication has 82 references indexed in Scilit:
- Hepatocellular carcinoma in HIV patients treated by liver transplantationEuropean Journal of Surgical Oncology, 2008
- HIV-Infected Liver and Kidney Transplant Recipients: 1- and 3-Year OutcomesAmerican Journal of Transplantation, 2008
- Kaposi’s sarcoma after liver transplantationJournal of Cancer Research and Clinical Oncology, 2007
- Effect of Highly Active Antiretroviral Therapy on Tacrolimus Pharmacokinetics in Hepatitis C Virus and HIV Co-Infected Liver Transplant Recipients in the ANRS HC-08 StudyClinical Pharmacokinetics, 2007
- Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV–HCV co-infected patientsJournal of Hepatology, 2005
- Options for Induction Immunosuppression in Liver Transplant RecipientsDrugs, 2002
- Review papers : The statistical basis of meta-analysisStatistical Methods in Medical Research, 1993
- Regression Analysis of Multivariate Incomplete Failure Time Data by Modeling Marginal DistributionsJournal of the American Statistical Association, 1989
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974